OAC
NEOS

OMERS Administration Corp’s Neos Therapeutics, Inc NEOS Stock Holding History

OMERS Administration Corp’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-46,360
Closed -$385K – 520
2018
Q1 		$385K Buy
46,360
+9,300
+25% +$88.8K ﹤0.01% 367
2017
Q4 		$378K Buy
+37,060
New +$356K ﹤0.01% 362
2017
Q3 		– Sell
-15,100
Closed -$110K – 537
2017
Q2 		$110K Buy
+15,100
New +$114K ﹤0.01% 447

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

OMERS Administration Corp's NEOS Position: Q2 2018 in Review

OMERS Administration Corp sold out of Neos Therapeutics, Inc (NEOS) in Q2 2018, closing a stake of 46,360 shares — an estimated $385K sold.

OMERS Administration Corp first reported a position in NEOS in Q2 2017 and held it in 3 quarters. The position peaked at $385K in Q1 2018. 73 funds tracked by Wall St. Rank hold NEOS as of Q2 2018.

  • OMERS Administration Corp reported no remaining Neos Therapeutics, Inc position as of Q2 2018 after selling out during the quarter.
  • OMERS Administration Corp sold 46,360 Neos Therapeutics, Inc shares in Q2 2018, an estimated $385K.
  • OMERS Administration Corp first reported a position in Neos Therapeutics, Inc in Q2 2017 and held it in 3 quarters.
  • OMERS Administration Corp's Neos Therapeutics, Inc position peaked at $385K in Q1 2018.
  • 73 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2018.

Based on OMERS Administration Corp's 13F filing for Q2 2018, filed 9 Aug 2018.